News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medtronic, Inc. (MDT) Looks To Overturn $393 Million Heart Valve Loss To Edwards Lifesciences Corporation (EW)



2/17/2014 8:23:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medtronic asks a Delaware federal judge to overturn a $393 million patent infringement loss to Edwards Lifesciences over their respective replacement heart valves. Medtronic (NYSE:MDT) asked a federal judge in Delaware this week to reverse a $393 million loss to Edwards Lifesciences (NYSE:EW) in their long-running patent infringement war over replacement heart valve technology. Last month a jury tagged Medtronic with the $393 million verdict, deciding that Medtronic's CoreValve device infringes a patent covering Edwards' Sapien device

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES